Advertisements

Rabeprazole Sodium

Quick links to important sections

Rabeprazole Sodium

Selected form

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Rabeprazole Sodium

Property Description
Active Ingredient Rabeprazole (as the sodium salt)
Form Enteric-coated, delayed-release tablet
Pharmacological Class Proton Pump Inhibitor (PPI)
General Purpose Sustained reduction of gastric acid secretion
Origin Synthetic compound

Rabeprazole Sodium: Definition and Pharmacological Class

Rabeprazole Sodium is a highly focused, synthetic gastrointestinal agent prescribed to manage conditions resulting from excessive gastric acidity. It is classified as a Proton Pump Inhibitor (PPI), a class of medication recognized for its potent ability to limit the production of stomach acid. The active component is the compound Rabeprazole, which is administered as its sodium salt to ensure stability and proper delivery. Rabeprazole is categorized as a substituted benzimidazole, which demonstrates its specific chemical structure and function. The compound demonstrates potential to provide relatively rapid acid suppression compared to some earlier-generation PPIs.

Composition and Enteric-Coated Delivery System

Rabeprazole Sodium is consistently formulated as an enteric-coated, delayed-release tablet intended for oral administration. This specialized preparation is essential because the Rabeprazole compound is inherently sensitive to degradation when exposed to the high acidity of the stomach lumen. The formulation utilizes a protective polymer coating that ensures the compound remains intact until it successfully reaches the higher pH environment of the small intestine for absorption. The primary mechanism involves irreversible inhibition of the proton pump, securing highly effective acid control. Popular brands containing this compound include AcipHex and Pariet, both using this specialized oral delivery format.

General Purpose of Acid Suppression

The overarching objective of Rabeprazole Sodium is to achieve reliable, sustained reduction of gastric acid secretion across the digestive cycle. By limiting the concentration of corrosive acid, the medication serves the fundamental therapeutic purpose of mitigating the chemical damage and irritation directed at the sensitive mucosal layers of the esophagus and stomach. This controlled environment is crucial for relieving discomfort associated with acid-related distress, such as that often experienced with severe heartburn. Promoting the body’s natural capacity for healing the affected tissues is the general benefit derived from this sustained acid suppression.

Regulatory References

  1. Rabeprazole
Advertisements

What side effects are possible with Rabeprazole Sodium?

Possible Side Effects and Safety Information

The safety profile for Rabeprazole Sodium is organized by regulatory authorities, classifying reported adverse reactions based on their frequency in clinical studies and the body system affected. Most commonly reported adverse reactions are defined as Common (geq1% to leq10%), while reactions reported less frequently are classified as Uncommon.

Adverse reactions are grouped according to the System-Organ Classes (SOC), including effects on the Gastrointestinal System, Nervous System, Skin, and Musculoskeletal System. Common adverse effects officially listed in regulatory documents include headache, nausea, diarrhea, vomiting, and abdominal pain. Uncommon effects may include joint pain (Arthralgia), muscle pain (Myalgia), rash, and somnolence (drowsiness).

Serious Adverse Reactions and Duration-Related Safety

Specific serious adverse reactions, often identified through post-marketing surveillance, are documented in official safety information. These include Severe Cutaneous Adverse Reactions (SCAR) such as Stevens-Johnson Syndrome (SJS), as well as Acute Interstitial Nephritis (AIN).

Regulatory documentation highlights risks associated with long-term exposure. This includes an increased risk of Bone Fracture (of the hip, wrist, or spine) and Hypomagnesemia (low blood magnesium levels), which is typically reported after three months to over a year of sustained daily use. Additionally, prolonged use may be associated with Cyanocobalamin (Vitamin B-12) deficiency and the development of Fundic Gland Polyps.

Official labeling advises caution in patients with severe hepatic impairment due to limited clinical data. The medication is formally contraindicated in individuals with known hypersensitivity to the drug or related compounds (substituted benzimidazoles), or for concomitant use with products containing rilpivirine.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory description of Rabeprazole Sodium overdosage indicates that acute overexposure typically results in effects that are minimal and reversible without the need for further specific medical intervention. Manifestations of overdose are generally reported to be representative of the known adverse event profile for this medication.

Required Emergency Actions

If an overdosage is suspected, regulatory guidance mandates seeking immediate medical attention or going to the hospital straight away. It is required to contact a poison control helpline promptly. When seeking assistance, individuals should be sure to take the tablets and the carton with them to the hospital to inform clinicians of the exposure details.

Urgent Help Thresholds

In situations where a severe or life-threatening event may be occurring, the official guidance is to immediately call emergency services. This urgent action is required if the person shows signs of collapse, has a seizure, experiences trouble breathing, or cannot be awakened (unresponsive).

Supportive Care and Antidote Status

Management of overdosage is officially directed toward symptomatic treatment and the utilization of general supportive measures. Regulatory documentation explicitly states that no specific antidote is known for Rabeprazole Sodium. Furthermore, due to the compound’s extensive protein binding, it is documented as not dialysable. No specific population-based alterations in overdose severity are noted in the official regulatory sections.

Advertisements

Therapeutic Uses of Rabeprazole Sodium

Understanding Rabeprazole Sodium

Rabeprazole sodium belongs to a class of medications known as proton pump inhibitors (PPIs). It works by reducing the amount of acid produced by the stomach, which helps manage conditions related to gastric acidity and promotes the healing of the digestive lining.

Primary Uses

Gastroesophageal Reflux Disease (GERD)

Rabeprazole sodium is commonly used to treat gastroesophageal reflux disease, a condition where stomach acid frequently flows back into the esophagus. This acid reflux can irritate the lining of the food pipe. The medication helps relieve symptoms such as heartburn and acid regurgitation. It is also used for the long-term maintenance and healing of erosive esophagitis, which involves visible damage to the esophagus caused by acid.

Gastric and Duodenal Ulcers

The medication is effective in treating active duodenal ulcers and benign gastric ulcers. By lowering acid levels, it allows these sores in the stomach or upper part of the small intestine to heal more efficiently.

Zollinger-Ellison Syndrome

Rabeprazole sodium is used to manage pathological hypersecretory conditions, such as Zollinger-Ellison syndrome. This is a rare condition where the stomach produces excessive amounts of acid due to the presence of specific tumors.

Helicobacter pylori Eradication

In combination with appropriate antibacterial therapeutic regimens, rabeprazole sodium is used to eradicate Helicobacter pylori (H. pylori). This bacterium is a common cause of recurring stomach ulcers. Reducing stomach acid during antibiotic treatment helps create an environment that supports the elimination of the infection.

Benefits and Therapeutic Goals

  • Symptom Relief: By suppressing acid production, the medication provides relief from the discomfort of chronic heartburn and indigestion.
  • Tissue Healing: Lowering acidity levels is essential for the repair of damaged esophageal and gastric tissues.
  • Prevention of Recurrence: In certain chronic conditions, regular use can prevent the return of symptoms or the redevelopment of erosions in the digestive tract.
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Rabeprazole Sodium

Population eligibility for Rabeprazole Sodium is defined strictly by official regulatory documents, which establish clear rules for permitted use, absolute non-eligibility, and conditional use.


Absolute Contraindications

The medicine is contraindicated in two primary groups. First, patients with a known hypersensitivity to the active ingredient, any component of the formulation, or to any other substituted benzimidazole (PPI class) must not use the medication. Second, concurrent use with rilpivirine-containing products is strictly prohibited as it may lead to loss of therapeutic effect for the rilpivirine regimen.


Age-Specific Eligibility and Restrictions

Age Group Eligibility Status
Adults (ge 18 years) Eligible for all approved uses.
Adolescents (12-17 years) Eligible for the short-term treatment of symptomatic GERD.
Children (< 1 year) Use is not recommended as safety and efficacy are not established.

No specific dosage adjustment is typically required for older adults (ge 65 years).


Conditional Use and Physiological States

Use in pregnant and breastfeeding women is generally not recommended due to insufficient data to establish safety, requiring a risk assessment by a prescriber. Caution is specifically advised for patients with severe hepatic impairment, due to limited clinical information on drug clearance in this population.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Rabeprazole Sodium's interaction profile is structured primarily by its effect on gastric pH and its hepatic metabolism, as documented in regulatory sources.


Contraindicated Combinations

Co-administration with Rilpivirine-containing medicinal products is contraindicated. This prohibition is due to the potential for Rabeprazole's acid suppression to significantly reduce Rilpivirine plasma concentrations, risking a loss of therapeutic effect.


Pharmacokinetic and Exposure-Modifying Interactions

Rabeprazole may significantly reduce the absorption of medicines whose bioavailability relies on an acidic stomach environment. Affected substances include the antifungals Ketoconazole and Itraconazole, as well as certain Antiretrovirals like Atazanavir and Nelfinavir. Conversely, Rabeprazole can increase the exposure of some co-administered drugs. For instance, co-administration with Digoxin has been documented to increase its trough plasma levels, and concomitant use with high-dose Methotrexate may elevate and prolong its serum concentrations.

Individuals identified as CYP2C19 poor metabolizers may exhibit higher systemic exposure of Rabeprazole itself due to reduced clearance, an officially noted population-specific pharmacokinetic consideration.


️ Other Documented Interactions

Use with Warfarin has been reported to cause an increase in INR and prothrombin time, necessitating careful monitoring. Additionally, long-term daily use (e.g., beyond three years) may reduce the absorption of Vitamin B12 (Cyanocobalamin).

Advertisements

Mechanism of Action

How Rabeprazole Sodium Works: Mechanism of Action

Rabeprazole is classified as a proton pump inhibitor, functioning through direct interaction with enzyme systems. The drug is a prodrug that requires activation within the highly acidic environment of the gastric parietal cells' secretory canaliculi. The active form then forms an irreversible covalent bond with the H^+/ K^+- ATPase enzyme, commonly known as the proton pump, which constitutes the final enzymatic step required for stomach acid secretion.

By permanently inactivating these pumps, Rabeprazole halts the fundamental release of acid, leading to a reduction in the concentration of hydrochloric acid in the stomach lumen. This inhibition is sustained because the drug binds irreversibly, meaning the effect persists until the body synthesizes and inserts new proton pump enzymes into the cell membrane. This prolonged inhibition, lasting up to 72 hours, results in a sustained reduction of acidity, characterizing the resulting physiological adjustment of the gastric environment.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Rabeprazole Sodium is administered via the oral route, typically as a 20 mg delayed-release tablet or as 5 mg or 10 mg delayed-release granules in capsule form. The delayed-release tablets must be swallowed whole and should not be chewed, crushed, or split, as this would compromise the enteric coating required for proper compound delivery.

Labeled Dosing and Timing

Administration frequency is predominantly once daily for most uses in adults, including short-term treatment and maintenance of healed erosive gastroesophageal reflux disease (GERD). However, for H. pylori eradication, the dose is 20 mg and is taken twice daily as part of a triple-drug combination regimen for 7 days.

In most cases, the tablets may be taken with or without food. Exceptions include treatment for duodenal ulcers, where the tablets are taken after the morning meal, and the H. pylori regimen, where the tablets are taken with the morning and evening meals. The standard adult dose for most indications is 20 mg, but starting doses for pathological hypersecretory conditions, such as Zollinger-Ellison Syndrome, may begin at 60 mg once daily and can be titrated higher.

Population-Specific Use

Pediatric dosing (1 to 11 years) for GERD uses the sprinkle granule formulation, with strengths of 5 mg or 10 mg once daily based on body weight. If a dose is missed, it should be taken as soon as possible, but two doses must never be taken at the same time. The use period ranges from short-term courses (e.g., up to 4 to 8 weeks) to continuous long-term use for specific conditions.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Rabeprazole Sodium

Evidence for Acute and Long-Term Mucosal Condition

Research examining the measurement of mucosal integrity related to erosive Gastroesophageal Reflux Disease (GERD) and duodenal ulcers primarily used short-term Randomized Controlled Trials (RCTs). These studies, involving adults and adolescents (12 years and older), tracked the endoscopically-confirmed condition of the esophageal and duodenal tissue after treatment periods of four to eight weeks. Subsequent long-term, placebo-controlled RCTs research examined the durability of the mucosal condition, typically for up to 12 months, in adults who had reached the initial healing endpoint. These studies monitored the duration for which the healed status was observed and the time elapsed before a symptomatic or structural relapse occurred.


Research on Symptom Outcomes and Infection Control

RCTs explored the role of Rabeprazole Sodium in managing symptom outcomes in patients with non-erosive GERD, relying heavily on patient-reported outcomes describing perceived discomfort, such as heartburn frequency. Research also focused on the medication’s role in multi-drug regimens for eliminating the H. pylori bacterium. Research examined the successful measurement of eradication rates when Rabeprazole was combined with specific antibiotics; outcomes may be influenced by factors like regional antibiotic resistance.


Evidence in Special Populations and Research Gaps

Studies monitored outcomes in pediatric patients (ages 1–11), but these trials are generally conducted with small sample sizes and sometimes lacked a placebo comparator. For rare conditions like Zollinger-Ellison Syndrome, evidence comes from long-term observational studies and case series due to the patient cohort size. There is limited information for long-term outcomes beyond the one-year mark in controlled maintenance trials, and a lack of controlled comparative data leaves subgroup findings uncertain.

Key Studies & References Pariet (rabeprazole) - European Public Assessment Report (EPAR) - Assessment History

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Rabeprazole Sodium (FAQ)


Q: What specific conditions does Rabeprazole Sodium treat besides acid reflux?

Official regulatory documents state that Rabeprazole Sodium is approved for treating conditions beyond simple acid reflux. These uses include helping to heal duodenal ulcers, eradicating the Helicobacter pylori bacterium (which causes some ulcers), and managing serious conditions involving excessive acid production, such as Zollinger-Ellison Syndrome.


Q: What are the common medical conditions Rabeprazole Sodium is prescribed for?

Rabeprazole Sodium is commonly prescribed for the short-term healing and long-term maintenance of erosive or ulcerative Gastroesophageal Reflux Disease (GERD). It is also frequently used as part of a multi-drug regimen to treat infections caused by the H. pylori bacterium and to heal certain ulcers in the digestive tract.


Q: How long is Rabeprazole Sodium typically recommended to be taken?

The duration of treatment depends entirely on the specific condition being addressed. For example, official guidelines recommend short-term use, such as four to eight weeks, for healing erosive GERD. However, the medication is also approved for continuous long-term maintenance therapy in certain chronic conditions.


Q: Is taking Rabeprazole Sodium for a long time considered safe?

Taking the medication for extended periods (typically defined as over one year) has been associated with certain risks noted in regulatory documents. These risks include an increased chance of bone fractures (hip, wrist, or spine), low magnesium levels (Hypomagnesemia), and Vitamin B12 deficiency. Regulatory documents indicate that when Rabeprazole is used continuously, regular medical surveillance is recommended.


Q: Are there interactions between Rabeprazole Sodium and general over-the-counter supplements?

Because Rabeprazole works by reducing stomach acid, it may reduce the absorption of some compounds that require an acidic environment to be absorbed. Official warnings mention that long-term use is associated with a reduction in Vitamin B12 absorption. Official patient counseling information emphasizes the importance of informing a healthcare provider about all supplements being taken.


Q: Does Rabeprazole Sodium interact with iron supplements or thyroid medications?

Regulatory information confirms that Rabeprazole Sodium may interfere with the body's absorption of certain iron salts. The drug can also affect the absorption of other pH-dependent medications, such as the thyroid medication levothyroxine. Regulatory information notes that co-administration with levothyroxine may reduce its effectiveness, which is why monitoring may be advised.


Q: What is the main difference between Rabeprazole Sodium and omeprazole?

Official regulatory bodies classify both Rabeprazole Sodium and omeprazole as Proton Pump Inhibitors (PPIs), meaning they share the same mechanism of action to reduce stomach acid. They belong to a chemical group called substituted benzimidazoles. Regulatory documents note that if a person is allergic to one PPI, they may have a potential cross-sensitivity reaction to others.


Q: Can Rabeprazole Sodium cause changes in mood or anxiety levels?

Official documents note that the drug can affect the nervous system, listing headache and somnolence (drowsiness) as common side effects. Less common or post-marketing reports mention nervousness or mental/mood changes, though specific anxiety as a labeled side effect is not consistently reported in primary regulatory sections.


Q: What symptoms indicate an allergic reaction to Rabeprazole Sodium?

Symptoms of a serious allergic reaction are described in official patient safety information. These symptoms include difficulty breathing or wheezing, swelling of the face, throat, or tongue, and hives or an itchy rash. The presence of such symptoms is noted to require professional evaluation.


Q: How quickly does Rabeprazole Sodium usually start to provide relief?

Rabeprazole is not an immediate-acting medication intended to stop acute heartburn right away. Official patient information states that it usually takes between 1 to 4 days for the medication to reach its full effect and start providing noticeable symptom relief.


Q: Is it normal not to feel an immediate reduction in acid levels when beginning treatment?

Yes, it is normal not to feel an immediate change in acid levels when beginning treatment. Regulatory patient information clarifies that the full therapeutic effect is typically reached after 1 to 4 days of taking the medication.


Q: What are the official guidelines regarding consuming alcohol while taking Rabeprazole Sodium?

Official product labels do not typically include explicit rules regarding alcohol consumption. However, regulatory review includes testing to ensure the delayed-release coating remains intact when exposed to varying levels of ethanol (alcohol), reducing the risk of premature drug release.


Q: Is it okay to use antacids like Tums or Maalox while taking Rabeprazole Sodium?

Yes, official patient counseling information states that it is generally okay to use antacids (like Tums or Maalox) while taking Rabeprazole Sodium if needed for breakthrough symptoms. Studies indicate that antacids do not significantly affect how the body absorbs Rabeprazole.


Q: Is Rabeprazole Sodium only available with a prescription?

Yes, according to the Food and Drug Administration (FDA) approval letters, Rabeprazole Sodium is classified as an approved prescription drug product and is only available with a doctor’s prescription.


Q: Why might Rabeprazole Sodium appear to stop working for some patients after extended use?

Regulatory warnings note that if symptoms persist or recur, other serious underlying conditions, such as malignancy, must be excluded. Additionally, differences in how an individual metabolizes the drug (related to the CYP2C19 enzyme) are also documented to influence the drug’s long-term exposure.


Q: Does Rabeprazole Sodium cause weight gain or weight loss as a reported side effect?

Changes in body weight are not listed as common side effects in the main clinical trial reports. However, some post-marketing surveillance reports have occasionally mentioned unusual weight gain or weight loss, though the frequency of this effect is not clearly established.


Q: Is the generic version of Rabeprazole Sodium therapeutically equivalent to the brand name?

Yes, the Food and Drug Administration (FDA) has officially determined that approved generic versions of Rabeprazole Sodium Delayed-Release Tablets are considered bioequivalent to the original brand-name product. This means the generic version is expected to work in the same way and provide the same therapeutic benefit.


Q: Are there interactions between Rabeprazole Sodium and herbal supplements?

Specific herbal interactions are not usually listed in official labels. Patient counseling information emphasizes the importance of informing your healthcare provider about all prescription, over-the-counter, and herbal products being used, as potential interactions may exist.

Advertisements

How should Rabeprazole Sodium be stored and disposed of?

Storage and Disposal of Rabeprazole Sodium

Rabeprazole sodium tablets must be stored at a controlled room temperature of 25°C (77°F), with temporary temperature excursions permitted between 15°C and 30°C (59°F and 86°F). To protect the delayed-release formulation, the product must be kept in its original container and the container must remain tightly closed and be protected from moisture.

Child Safety and Disposal

The medication must always be stored out of the reach of children. For unused or expired Rabeprazole Sodium, official labeling requires disposal according to local regulations. Individuals should consult a pharmacist or healthcare professional for guidance on proper drug disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Rabeprazole Sodium found in:

A-Z Index: